Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
<p>Abstract</p> <p>Background</p> <p>Treatment guidelines recommend LDL-C as the primary target of therapy in patients with hypercholesterolemia. Moreover, combination therapies with lipid-lowering drugs that have different mechanisms of action are recommended when it i...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-07-01
|
| Series: | Lipids in Health and Disease |
| Online Access: | http://www.lipidworld.com/content/9/1/80 |